Search results
Raleigh Capital Management Inc. Has $2.67 Million Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 6 days agoRaleigh Capital Management Inc. grew its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.9% during the 4th quarter, according to the company in its most recent disclosure ...
2 Dividend Stocks That Could Pay You for Life | The Motley Fool
The Motley Fool· 6 days agoPeople invest in dividend stocks for various reasons. Let's consider two examples: AbbVie (ABBV...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Tri-County Times· 4 days agoAbbVie logo (PRNewsFoto/AbbVie)
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 3 days agoFree Report) announced that the FDA has granted approval to its blockbuster drug, Skyrizi to treat adults with moderately to severely active ulcerative colitis (UC) in the United States. Skyrizi ...
Humira: the highs and lows of the world’s best-selling drug
Pharmaceutical Technology via Yahoo Finance· 4 days agoHumira, an arthritis medication with indications for colitis and psoriasis is the world’s...
Why AbbVie (ABBV) is a Great Dividend Stock Right Now
Zacks· 3 days agoCash flow can come from bond interest, interest from other types of investments, and of course, dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's ...
Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades' - NVIDIA...
Benzinga· 5 days agoOn CNBC's Halftime Report, Bryn Talkington picked NVIDIA, Jim Lebenthal chose Vertex...
Here's Why AbbVie (ABBV) is a Strong Momentum Stock
Zacks via Yahoo Finance· 3 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks· 1 day agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Imfinzi.
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years - AbbVie (NYSE:ABBV)
Benzinga· 2 days agoAbbVie ABBV has outperformed the market over the past 10 years by 1.28% on an annualized basis producing an average annual return of 12.11%. Currently, AbbVie< ...